NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer

SIMPLE SUMMARY: Triple negative breast cancer is an aggressive breast cancer subtype with limited targeted therapeutic options. As a method of identifying novel therapeutic targets in this disease subtype, we utilize a microRNA that reverses the Epithelial-to-Mesenchymal Transition, which reveals Ni...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neill, Kathleen I., Kuo, Li-Wei, Williams, Michelle M., Lind, Hanne, Crump, Lyndsey S., Hammond, Nia G., Spoelstra, Nicole S., Caino, M. Cecilia, Richer, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319388/
https://www.ncbi.nlm.nih.gov/pubmed/35884604
http://dx.doi.org/10.3390/cancers14143543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319388/
https://www.ncbi.nlm.nih.gov/pubmed/35884604
http://dx.doi.org/10.3390/cancers14143543

Ejemplares similares